Challenges Likely to Face Cannabis Industry in 2023

Published:

The cannabis industry has grown drastically in the past decade, and this rapid growth is expected to continue. With the legalization of cannabis on a state level, more businesses are entering the market, and investors are pouring money into the industry. However, with such fast-paced development, several possible challenges could be faced in 2023.

The rapid growth of the cannabis industry means that there is increased competition in the market. This could lead to pricing wars, as producers and businesses try to undercut each other to gain customers. Additionally, with an influx of new companies, regulation may become lax, and quality control may not be enforced. Here are some of the common challenges likely to face the cannabis industry in 2023;

The COVID-19 Pandemic’s Effects

The pandemic has already caused disruptions to businesses and consumers around the world. The cannabis industry is no exception, as it has seen a decrease in sales due to safety protocols, lockdowns, and people’s hesitance to purchase products from dispensaries. Moreover, with economic instability, fewer people may be willing to invest in this industry.

Although the pandemic is past us, its effects may continue to be felt in 2023. For example, if the economy continues to struggle, people may not be able to purchase cannabis products as freely.

Regulations and Legalization

In some states, cannabis is still illegal or heavily regulated, making it difficult for businesses to operate in those areas. With legalization on a state level relatively new, there are still grey areas regarding regulations that need to be addressed. In 2023, businesses may face difficulties if these regulations are not clearly defined and enforced.

The fact that regulations vary from state to state can lead to confusion and frustration among cannabis businesses. To stay compliant, these businesses must be aware of any changes in regulations in the states they operate in. This means that businesses should stay alert just in case anything pops up.

Technology

As with most industries, technology plays a more significant role in the cannabis industry. Automation and digitalization are being used more frequently, from production processes like growing to sales strategies. 2023 may present new opportunities and challenges regarding using technology in the cannabis industry.

For example, as digital marketing becomes more popular, companies must find ways to stand out and appeal to customers. Additionally, businesses must ensure that their data is secure from hackers and malicious actors.

Consumer Behavior

Consumer behavior is constantly changing, and in the cannabis industry, it can be incredibly unpredictable as attitudes shift toward its usage. In 2023, businesses must stay on top of trends to remain competitive and successful. They must understand their customers’ needs and ensure they meet them. Additionally, businesses need to stay up-to-date on new products and technologies to keep up with the industry’s changing environment.

Societal Stigma

Many people still view cannabis as an illicit substance, despite its legal status in many states. This stigma can affect the way people view and purchase cannabis products, leading to a decrease in sales and market growth. In addition, this stigma could lead to less access to capital for businesses in this industry.

In 2023, cannabis companies must work to combat these stigmas and ensure that the public is aware of its positive effects. They should focus on educating their customers and creating an environment of acceptance and understanding around cannabis usage.

The cannabis industry is rapidly growing and changing, thus presenting opportunities and challenges. In 2023, businesses must remain aware of all the potential risks that come with the industry and be prepared to take them on head-on. With careful planning and a keen eye for new trends, cannabis companies can navigate these obstacles and grow their business.

Disclaimer

The information provided in this article is intended for informational purposes only and does not constitute medical, legal, pharmaceutical, or professional advice of any kind. Express Highs makes no representations or warranties regarding the accuracy, completeness, or suitability of the content for any particular purpose. Readers should not rely on this content as a substitute for advice from a qualified medical professional, legal counsel, or other relevant expert.
The products and substances discussed on this blog may be subject to varying legal restrictions depending on your country, region, or jurisdiction. It is the sole responsibility of the reader to be aware of and comply with all applicable local, national, and European Union laws and regulations before purchasing, possessing, or using any product referenced herein. Express Highs accepts no liability for any consequences arising from actions taken based on the content of this article.
This blog is intended for adults only. By reading this content, you confirm that you are of legal age in your jurisdiction.
Nothing in this article is intended to diagnose, treat, cure, or prevent any disease or medical condition. Any health-related claims discussed are not evaluated by the European Food Safety Authority (EFSA) or any other regulatory body unless explicitly stated.
Express Highs reserves the right to update or remove content at any time without notice. All content is published in good faith and for general informational purposes only.

Alex Marin
Alex Marinhttps://blog.expresshighs.com
Alex Marin is a harm reduction writer, independent researcher, and longtime observer of emerging psychoactive trends. With over a decade spent navigating the shifting landscape of cannabinoids, research chemicals, and psychedelic culture, Alex specializes in translating complex pharmacology and policy changes into practical, real-world guidance. Drawing on a background in behavioral science and grassroots drug education, Alex’s work focuses on one core principle: informed choices reduce harm. From first-time cannabis users to experienced psychonauts, their writing is designed to meet readers where they are—without judgment, hype, or fearmongering. Alex has contributed to multiple online publications covering CBD science, evolving drug laws, and safer-use strategies. At the Express Highs Blog, they break down topics like dosage, substance interactions, and risk awareness—helping readers navigate a fast-moving market where new compounds and regulations appear almost daily. When not writing, Alex collaborates with harm reduction communities, tracks global policy shifts, and tests the latest data against real-world user experiences. Their goal is simple: clear information, fewer bad trips, and smarter decisions.

Related articles

Recent articles